Respiratory Rare Disease Trials — Optimizing Diversity and Decentralization

Francis Jones is the Senior Director in the PPD Infectious, Respiratory and Critical Care Diseases group with more than 23 years of drug development experience working for Pharma and CRO. His current role focuses on respiratory clinical trial strategy development — early engagement, proposal writing, reviewing trial protocols and helping clients design optimized clinical trials. Francis has extensive experience leading global clinical trials across a range of respiratory indications and received his Pharmacology PhD from Cardiff Medical School in the UK.

Christian Lloyd is a board-certified Pulmonary/Critical/Sleep specialist since 2002. Christian Joined PPD/ Thermo Fisher Scientific in 2021. Before joining PPD, Christian served as the Director of Medical Intensive Care Services for a large referral healthcare system. Christian completed a Master of Health Care Administration at the University of North Carolina in 2017 and is passionate about critical care delivery, therapeutic product development and approval as well as improving value-based healthcare delivery.

Terri Myers serves as vice president and global head of PPD Biotech operations where she oversees operational and partnership delivery models tailored to meet the needs of our rapidly growing biotech clients. Terri has held clinical research roles the past 23 years, including a proven 17-year history in operations and strategic solution development working in various capacities in the complex space of rare disease development. Myers completed her Master of Business Administration at the University of North Carolina, Wilmington, and holds a bachelor’s degree in economics with a minor in international studies from Wake Forest University.